Overview

The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study

Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
All
Summary
Open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Treatments:
Armodafinil
Modafinil
Criteria
Inclusion Criteria:

- solid cancer patient

- age of 20-65 years old

- subjects who scored =4 or >4 on the Brief Fatigue Inventory

- subjects with informed consent

Exclusion Criteria:

- metastatic cancer(stage IV)

- with psychotic symptoms such as delusion and hallucination or with suicidal risk

- with delirium or dementia

- current medication of cognitive enhancer or psychostimulant uncontrolled medical
illness

- current medications that are contraindicated or not recommended for co-administration
with modafinil